Article R5121-76-8
The cost of monitoring treated patients is borne by the marketing authorisation holder for the medicinal product or by the company which operates the medicinal product and which has been authorised to…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 3681–3690 of 37590 articles for “Art. 815-3 al. 8”
The cost of monitoring treated patients is borne by the marketing authorisation holder for the medicinal product or by the company which operates the medicinal product and which has been authorised to…
The Director General of the Agence nationale de sécurité du médicament et des produits de santé may suspend or withdraw a compassionate access authorisation if the conditions laid down in I, II and V…
In the event of interruption or cessation of activity of an establishment or organisation mentioned in article L. 4211-9-1, the data relating to the traceability of advanced therapy medicinal products…
If the société de participations financières de profession libérale de pharmaciens d'officine ceases to comply with the legislative and regulatory provisions in force, it is given formal notice by the…
When a training organisation holding a registration number provides an apprenticeship training course for the first time, it must send a copy of its articles of association to the Regional Prefect wit…
When the validation of acquired experience takes place during working hours, as part of the skills development plan, the mobilisation of the personal training account, a leave to validate acquired exp…
The authorisation provided for in Article R. 5132-88 is issued by the Director General of the Agence nationale de sécurité du médicament et des produits de santé, after obtaining the opinion of the Di…
The cultivation, import, export and use, for industrial and commercial purposes, of varieties of Cannabis sativa L. without narcotic properties or products containing such varieties are authorised by…
Establishments or organisations authorised under Article L. 513-11-1 shall send the Director General of the Agence nationale de sécurité du médicament et des produits de santé an annual activity repor…
The health care establishment authorised to carry out the activity of exceptional organ or tissue transplantation or composite vascularised tissue transplantation must be able to ensure its implementa…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More